Compile Data Set for Download or QSAR
Report error Found 47 Enz. Inhib. hit(s) with all data for entry = 50032604
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331806(methyl 3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybu...)
Affinity DataIC50: 7.90nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331797(1-(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-...)
Affinity DataIC50: 11nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331794(1,1,1-trifluoro-2-(1-((2-(hydroxymethyl)-3-phenylb...)
Affinity DataIC50: 19nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331803((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 21nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331801((S)-3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan...)
Affinity DataIC50: 28nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331802((S)-3-(3-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 31nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331801((S)-3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan...)
Affinity DataIC50: 32nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331802((S)-3-(3-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 39nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331807(1,1,1-trifluoro-2-(1-((3-phenylbenzo[b]thiophen-6-...)
Affinity DataIC50: 40nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331803((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 55nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331800(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-2-y...)
Affinity DataIC50: 55nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331794(1,1,1-trifluoro-2-(1-((2-(hydroxymethyl)-3-phenylb...)
Affinity DataIC50: 64nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331800(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-2-y...)
Affinity DataIC50: 70nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331797(1-(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-...)
Affinity DataIC50: 84nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331796(1,1,1-trifluoro-2-(1-((2-(1-hydroxyethyl)-3-phenyl...)
Affinity DataIC50: 88nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331804((R)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 154nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331796(1,1,1-trifluoro-2-(1-((2-(1-hydroxyethyl)-3-phenyl...)
Affinity DataIC50: 161nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331795(1,1,1-trifluoro-2-(1-((2-(2-hydroxypropan-2-yl)-3-...)
Affinity DataIC50: 198nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331799(N-methyl-3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxy...)
Affinity DataIC50: 223nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331806(methyl 3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybu...)
Affinity DataIC50: 260nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331799(N-methyl-3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxy...)
Affinity DataIC50: 263nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331795(1,1,1-trifluoro-2-(1-((2-(2-hydroxypropan-2-yl)-3-...)
Affinity DataIC50: 392nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331807(1,1,1-trifluoro-2-(1-((3-phenylbenzo[b]thiophen-6-...)
Affinity DataIC50: 598nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331804((R)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 1.16E+3nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331798(N,N-dimethyl-3-phenyl-6-((4-(1,1,1-trifluoro-2-hyd...)
Affinity DataIC50: 1.84E+3nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331798(N,N-dimethyl-3-phenyl-6-((4-(1,1,1-trifluoro-2-hyd...)
Affinity DataIC50: 1.89E+3nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331795(1,1,1-trifluoro-2-(1-((2-(2-hydroxypropan-2-yl)-3-...)
Affinity DataKi:  2.60E+3nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331796(1,1,1-trifluoro-2-(1-((2-(1-hydroxyethyl)-3-phenyl...)
Affinity DataKi:  3.80E+3nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331797(1-(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-...)
Affinity DataKi:  4.40E+3nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331806(methyl 3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybu...)
Affinity DataKi:  6.30E+3nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331805((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331793(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-2-y...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant 5-lipoxygenase assessed as arachidonic acid oxidationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331804((R)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataKi:  1.10E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331803((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataKi:  1.30E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331794(1,1,1-trifluoro-2-(1-((2-(hydroxymethyl)-3-phenylb...)
Affinity DataKi:  1.30E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331802((S)-3-(3-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataKi:  1.40E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331801((S)-3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan...)
Affinity DataKi:  1.60E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331800(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-2-y...)
Affinity DataKi:  1.70E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331805((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataKi: >2.00E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331803((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of 12-lipoxygenaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331805((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid lipoxygenase ALOX15(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331803((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of 15-lipoxygenaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetArachidonate 5-lipoxygenase-activating protein(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331803((S)-3-(4-fluorophenyl)-6-((4-(1,1,1-trifluoro-2-hy...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of 5-lipoxygenase activating proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331798(N,N-dimethyl-3-phenyl-6-((4-(1,1,1-trifluoro-2-hyd...)
Affinity DataKi: >2.00E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331799(N-methyl-3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxy...)
Affinity DataKi: >2.00E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331793(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-2-y...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of 5-lipoxygenase in human whole blood assessed as inhibition of LTB4 productionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50331793(3-phenyl-6-((4-(1,1,1-trifluoro-2-hydroxybutan-2-y...)
Affinity DataKi: >2.00E+4nMAssay Description:Displacement of labeled MK-499 from human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed